Island cancer patients benefitting from fast bladder treatment

Cancer patients on the Isle of Wight are benefiting from faster treatment and shorter hospital stays. Improvements at St Mary’s Hospital mean patients who previously needed overnight care can now ...

UroGen Pharma Ltd. Q4 2025 Earnings Call Summary

Moby Strategic Execution and Commercial Foundation. Management attributes the early 2025 Zasturi revenue of $15.8 million to a d ...

ZUSDURI™ Achieves Durable Complete Responses Across EORTC Risk Groups in Patients with Recurrent LG-IR-NMIBC

EORTC Recurrence Score Analysis from the Pivotal ENVISION Trial to be Presented at the 2026 American Society of Clinical Oncology’s ...

UroGen Announces ZUSDURI™ Launch is On-Track and Reports Fourth Quarter and Full Year 2025 Financial Results

Commercial launch is on-track for ZUSDURI™, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk ...

UroGen Pharma Ltd.: UroGen Announces ZUSDURI Launch is On-Track and Reports Fourth Quarter and Full Year 2025 Financial Results

Commercial launch is on-track for ZUSDURI, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC); net sales ...
Healthline

Septal Myectomy: Surgery for Hypertrophic Cardiomyopathy (HCM)

Septal myectomy removes part of a thickened septum to treat hypertrophic cardiomyopathy (HCM) with left ventricular outflow tract obstruction. It can improve severe symptoms that do not respond to ...